ADVANCING EARLY DRUG DISCOVERY
Dead / Abandoned — Abandoned — no statement of use filed (as of 25 Jun 2018)
What this means for you
This application is over — abandoned 25 Jun 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87207564
- Mark type
- Stylized text
- Filed
- 18 Oct 2016
- Published for opposition
- 26 Sept 2017
- Abandoned
- 25 Jun 2018
- Attorney of record
- Rachelle A. Dubow,
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development services; drug discovery services, namely, assay optimization and miniaturization, method development, high throughput screening, high throughput confirmation and dose response, deconvolution of complex samples, synthetic chemistry, medicinal chemistry, compound logistics, purification, analytics and computational chemistry for early drug discovery research and development
Owner
- Icagen, Inc., Durham, NC, US
- Icagen, Inc., Durham, NC, US
Prosecution history
- 24 Oct 2018 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 19 Sept 2018 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 25 Jun 2018 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 25 Jun 2018 — ABANDONMENT - NO USE STATEMENT FILED
- 21 Nov 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Sept 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Sept 2017 — PUBLISHED FOR OPPOSITION
- 06 Sept 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Aug 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Jul 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Jul 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Jul 2017 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Jan 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Jan 2017 — NON-FINAL ACTION E-MAILED
- 31 Jan 2017 — NON-FINAL ACTION WRITTEN